Journals / Psikiyatride Güncel Yaklaşımlar / 2011 / Cilt: 3 - Sayı: 2

Metabolic and Endocrine Side Effects of Atypical Antipsychotic Drugs in Children and Adolescents

Çocuk ve Ergenlerde Atipik Antipsikotik İlaçların Metabolik ve Endokrin Yan Etkileri

Pages
232–250
Publication Date
2011-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, we briefly reviewed metabolic side effects of second generation antipsychotic drugs in child and adolescent population, possible mechanisms of susceptibility to metabolic syndrome and pharmacological and non pharmacological treatment approach to prevention of weight gain.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Comorbid psychiatric disorders, frequent hospitalization, multiple outpatient treatment, prior history of hypertension, obesity and lipid dysregulation are associated with higher risk of metabolic syndrome in children.
📊
Key Findings & Data:Prevention strategies are usually preferred to secondary or tertiary strategies in the management of metabolic syndrome associated with antipsychotic drugs.
💡
Conclusion & Impact:In this paper, we briefly reviewed metabolic side effects of second generation antipsychotic drugs in child and adolescent population, possible mechanisms of susceptibility to metabolic syndrome and pharmacological and non pharmacological treatment approach to prevention of weight gain.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:metabolik sendrom · atipik antipsikotikler · yan etkiler

Abstract

Comorbid psychiatric disorders, frequent hospitalization, multiple outpatient treatment, prior history of hypertension, obesity and lipid dysregulation are associated with higher risk of metabolic syndrome in children. Side effects of antipsychotic drugs and their management have recently become a major subject of research due to enhanced antipsychotic drug usage in child and adolescents. Prevention strategies are usually preferred to secondary or tertiary strategies in the management of metabolic syndrome associated with antipsychotic drugs. Clinicians should present multidisciplinary approach to endocrine and metabolic side effects due to antipsychotic use in pediatric patient groups and avoid multiple drug use in such patients. In this paper, we briefly reviewed metabolic side effects of second generation antipsychotic drugs in child and adolescent population, possible mechanisms of susceptibility to metabolic syndrome and pharmacological and non pharmacological treatment approach to prevention of weight gain.

Özet

Çocuklarda eş tanılı psikiyatrik bozukluklar, sık hastaneye yatış, ayaktan tedavi başvurularının fazlalığı ve hipertansiyon, obezite ve lipid bozuklukları öyküsü yüksek metabolik sendrom riski ile ilişkilendirilmiştir. Çocuk ve ergenlerde antipsikotik ilaç kullanımının artması nedeniyle ilaç yan etkileri ve bu yan etkilerin yönetimi de önem kazanmaktadır. Literatürde genel olarak antipsikotiklerle ilişkili metabolik sendromda önleyici yaklaşımların ikincil ve üçüncül yaklaşımlara göre daha çok tercih edildiği vurgulanmıştır. Klinisyenlerin çocuk ve ergen hasta grubunda antipsikotik ilaç kullanımına bağlı endokrin ve metabolik yan etkilere multidisipliner yaklaşım sergilemeleri ve çoklu ilaç kullanımından kaçınmaları önerilmektedir. Bu yazıda çocuk ve ergen hasta grubunda ikinci kuşak antipsikotik ilaçların metabolik yan etkileri, metabolik sendroma yatkınlığın olası nedenleri ve kilo artışını önlemeye yönelik farmakolojik ve farmakolojik olmayan tedavi yaklaşımları kısaca gözden geçirilmiştir.

🔖

Cite This Article

Çelik, G. G., Tahiroğlu, A., Avcı, A. (2011). Metabolic and Endocrine Side Effects of Atypical Antipsychotic Drugs in Children and Adolescents. Psikiyatride Güncel Yaklaşımlar, Cilt: 3 - Sayı: 2, 232–250. https://ajindex.com/articles/230178

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF et al. A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2008; 2:26. Pappadopulos E, Macintyre Ii JC, Crismon ML, Findling RL, Malone RP, Derivan A et al.Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. J Am Child Adolesc Psychiatry. 2003; 42:145-161.
  2. Keefe RS, Silva SG, Perkins DO, Lieberman J. Effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and metaanalysis. Schizophr Bull 1999; 25:201-222.
  3. Cooper WO, Arbogast PG, Ding H, Hickson GB, Fuchs DC, Ray WA. Trends in prescribing of antipsychotic medications for US children. Ambul Pediatr 2006; 6:79 Olfson M, Blanco C, Lui L, Moreno C, Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 2006; 63: 679- 685. Taş F, Güvenir T, Miral S. Bir çocuk ve ergen psikiyatrisi kliniğinde yatarak tedavi gören hastalarda ilaç kullanımı. Çocuk ve Gençlik Ruh Sağlığı Dergisi 2007; 14:139- 150. McIntyre RS, Jerrell JM. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. Arch Pediatr Adolesc Med 2008;
  4. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new world wide definition. Lancet 2005; 366(9491):1059-1062.
  5. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-359. Öyekçin DG. Bir grup şizofreni ve şizoaffektif bozukluk hastasında metabolik send- rom sıklığı. Anadolu Psikiyatri Dergisi 2009; 10:26-33.
  6. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 1994; 157:821- 827. Dhillo WS. Appetite regulation: an overview. Thyroid 2007; 17: 433-445.
  7. Fernandez JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African American, European- American, and Mexican-American children and adolescents. J Pediatr 2004; 145:439- 444. Correll CU, Carlson HE. Endocrin and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry 2